| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9320323 | European Urology | 2005 | 6 Pages |
Abstract
During the 6-week period the intermediate weekly BCG instillations 2, 3, 4, and 5 do not contribute to Th1 cytokine upregulation in the bladder, provided that the BCG dose is sufficient. Whether such a reduced BCG frequency schedule has immunestimulating capacity and therapeutic efficacy associated with less side effects in patients remains to be investigated.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Elizabeth C. de Boer, Sietske J. Rooyakkers, Denis H.J. Schamhart, Theo M. de Reijke, Karl-Heinz Kurth,